Natcofarma

Generic Pharmaceuticalsnatcofarma.com

Natcofarma do Brasil is a São Paulo-based pharmaceutical subsidiary of India-headquartered Natco Pharma Limited, producing active pharmaceutical ingredients and finished medicines for the Brazilian market with a headcount of 51-100 employees.

Company typePrivate
Founded2011
HeadquartersSão Paulo, Brazil
Headcount101–250
GTM typeB2B
OfferingHardware or Manufacturing

What Natcofarma does

Natcofarma do Brasil is a Brazilian pharmaceutical company operating as a subsidiary of India-headquartered Natco Pharma Limited. Founded in 2010 and headquartered in São Paulo, the company is engaged in the production of active pharmaceutical ingredients (APIs) and finished medicines for the Brazilian market, with a reported headcount of 51-100 employees. It is structured as a for-profit, privately held entity.

The subsidiary's strategic rationale appears to be geographic expansion of Natco Pharma's generics and API franchise into Latin America via a locally incorporated distribution and manufacturing foothold. Operationally, however, public visibility is limited: the company's primary web domain (natcofarma.com) returns only a loading/verification page, and no product catalog, certifications, management roster, customer base, partnerships, pricing model, or revenue figures could be confirmed from the available sources.

No funding rounds, M&A transactions, product launches, regulatory actions, leadership changes, or partnership announcements were disclosed in the supplied material. The available data therefore supports a narrow factual profile — a mid-sized, privately held pharma subsidiary in São Paulo, backed by an established Indian parent — and does not support deeper claims about technology stack, go-to-market mechanics, or financial trajectory.

Natcofarma firmographics

Firmographics

Name: Natcofarma
Website: https://natcofarma.com
Company type: Private
Founded year: 2011
Headcount range: 101–250 employees
Short description: Natcofarma do Brasil is a São Paulo-based pharmaceutical subsidiary of India-headquartered Natco Pharma Limited, producing active pharmaceutical ingredients and finished medicines for the Brazilian market with a headcount of 51-100 employees.
Ownership category
akta.pro rank

Where Natcofarma is headquartered

Location

Headquarters

HQ city: São Paulo
HQ country: Brazil
HQ region: Latin America

Markets served

Natcofarma business model

Business model

GTM type: B2B
Offering type: Hardware or Manufacturing
Cost components: Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Natcofarma product offering

Product offering

Core offering

Natcofarma do Brasil is a pharmaceutical manufacturing subsidiary of Natco Pharma Limited that produces active pharmaceutical ingredients (APIs) and finished medicines for the Brazilian market. Operating from São Paulo since 2010, the company manufactures generic pharmaceutical products using its parent's established pharmaceutical technology and expertise.

Differentiator

Problem solved

Functional benefit

Products and services

Active Pharmaceutical Ingredients (APIs) Active pharmaceutical ingredients manufactured in São Paulo, Brazil, serving other pharmaceutical companies and formulators that require raw API inputs for finished drug production.
Finished Pharmaceutical Medicines Finished generic pharmaceutical medicines produced at Natcofarma's São Paulo facility for distribution to the Brazilian pharmaceutical market.

Companies that use Natcofarma

Customer profile

Ideal customer profiles1 record

Natcofarma technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Natcofarma partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights1 record

Natcofarma competitors and assessment

Company assessment

Emerging players

Glenmark Pharmaceuticals: Indian pharmaceutical company with growing Brazilian and Latin American presence, focused on generics and specialty products. Comparable as another India-rooted player building out Brazilian operations.

Broad incumbents

Aurobindo Pharma: India-headquartered global API and generics manufacturer with significant Latin American exposure. Highly comparable to Natco Pharma as an Indian API/formulation player expanding into Brazil.
Sandoz (Novartis): Global leader in off-patent medicines (generics and biosimilars) with a strong Brazilian commercial footprint and vertically integrated manufacturing. Comparable to Natcofarma on finished generics distribution in Brazil.
Teva Pharmaceutical Industries: World's largest generic medicines manufacturer with significant API production and operations across Latin America, including Brazil. Comparable to Natcofarma on API + generics exposure, though at vastly greater scale.
Hypera Pharma: Largest Brazilian pharma company by market cap, producing branded generics, OTC, and prescription products across a broad portfolio. Competes in the same Brazilian generics market as Natcofarma but at materially greater scale.
Dr. Reddy's Laboratories: Indian multinational pharmaceutical company producing APIs and finished generics with established Brazilian commercial operations. Closely comparable to Natco Pharma (Natcofarma's parent) and a likely competitive analogue.

Direct peers

Aché Laboratórios Farmacêuticos: Top-5 Brazilian pharmaceutical manufacturer producing prescription, OTC, and generics with in-house API capabilities. Comparable to Natcofarma as a domestic manufacturer competing in the same Brazilian generics market.
Cristália Produtos Químicos Farmacêuticos: Brazilian pharmaceutical and API manufacturer with vertically integrated production of APIs and finished dosage forms, including specialty and controlled substances. Directly comparable to Natcofarma on API + formulation integration.
Eurofarma Laboratórios: Major Brazilian pharmaceutical company with vertically integrated API and finished-dose manufacturing, serving both domestic and Latin American markets. Comparable to Natcofarma on manufacturing scope and regional footprint.
EMS Farmacêutica: Brazil's largest domestic pharmaceutical manufacturer, producing generics, branded generics, APIs, and finished medicines for the Brazilian market. Most directly comparable to Natcofarma by product mix (APIs + finished doses) and end-market (Brazil).

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks3 records

Key highlights4 records

Customer concentration

Natcofarma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Natcofarma leadership team

Management profile

Number of profiles

Natcofarma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Natcofarma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Natcofarma

What does Natcofarma do?

When was Natcofarma founded?

Natcofarma was founded in 2011. It employs 101 to 250 people.

Where is Natcofarma based?

Natcofarma is headquartered in São Paulo, Brazil, in the Latin America region.

Who are Natcofarma's main competitors?

Glenmark Pharmaceuticals is listed as an emerging player. Broad incumbents are Aurobindo Pharma, Sandoz (Novartis), Teva Pharmaceutical Industries, Hypera Pharma and Dr. Reddy's Laboratories. Direct peers are Aché Laboratórios Farmacêuticos, Cristália Produtos Químicos Farmacêuticos, Eurofarma Laboratórios and EMS Farmacêutica.

Does Natcofarma have an API?

No public API is recorded for Natcofarma.